Travere Therapeutics (TVTX) Capital Expenditures (2013 - 2025)
Travere Therapeutics (TVTX) posted Capital Expenditures of $140,000 for Q3 2025.
Powered by 
Analysis
Travere Therapeutics (TVTX) Capital Expenditures (2013 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Capital Expenditures at Travere Therapeutics was $222,000, up 107.5% year-over-year; for FY2023, it came in at $668,000, up 249.7% from FY2022.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -1.7% (FY2018 to FY2023).
- In prior years, Travere Therapeutics' Capital Expenditures was $191,000 in FY2022 (-96.3%), $5.1 million in FY2021 (-24.6%), $6.77 million in FY2020 and $195,000 in FY2019 (-73.2%).
- The Q3 2025 figure stands as the highest quarterly Capital Expenditures since Q1 2023.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2023, with growth of 380.9%; the weakest was Q1 2022, with a decline of 97.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 140,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 630,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Sep 30, 2021 | 349,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Mar 31, 2021 | 4.50 Mn |
| Dec 31, 2020 | 3.84 Mn |
| Sep 30, 2020 | 2.41 Mn |
| Jun 30, 2020 | 310,000.00 |
| Mar 31, 2020 | 208,000.00 |
| Dec 31, 2019 | -91,000.00 |
| Sep 30, 2019 | 265,000.00 |
API Access
Travere Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();